Table 1 Association between clinicopathological characteristics and level of Bcl-xL protein expression in 175 UTUC patients

From: Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma

Variables

n

Bcl-xL score

P

Age

<65 years

73

6.88±3.68

 

⩾65 years

102

5.96±3.63

0.085

Gender

Male

131

6.17±3.59

 

Female

44

7.48±3.80

0.031

Tumour stage

<pT2

57

4.70±3.31

 

⩾pT2

118

7.36±3.54

<0.001

Grade

Low

64

5.56±3.40

 

High

111

7.04±3.74

0.007

Tumour location

Pelvis

103

6.48±3.59

 

Ureter

72

6.53±3.83

0.993

LVI

Negative

119

5.84±3.62

 

Positive

56

7.89±3.43

0.001

  1. Abbreviations: LVI=lymphovascular invasion; UTUC=urinary tract urothelial carcinoma.
Back to article page